Summary
The regulation of murine mammary tumor virus (MuMTV) production by mammotropic hormones, hormonomimetic substances, and cyclic nucleotides was investigated. The virus produced in control and treated mammary tumor cell cultures was quantitated by measuring the supernatant reverse transcriptase activity in exogenous reaction using poly(rC). oligo(dG) as templateprimer. Two days after exposure, the synthetic clucocorticoid, dexamethasone (DXMT), increased spontaneous MuMTV production at optimal concentration (0.1 μmol) up to ten times. Dibutyryl derivative of cyclic AMP had no effect on spontaneous MuMTV production, whereas the drug potentiated suboptimal concentrations of the glucocorticoid. Natural prostaglandins, potent agonists of adenylate cyclase catalyzing intracellular synthesis of cyclic AMP, enhanced both basal (up to five times) and DXMT-stimulated (up to 1.6 times) MuMTV replication. The MuMTV-stimulating activity of prostaglandins decreased in the order of PGA1>PGE1>PGB1>PGF2α. Prostaglandins can be replaced partially by norepinephrine and isoproterenol by enhancing the DXMT-mediated MuMTV stimulation, whereas these drugs remained without effect on spontaneous MuMTV production. Theophylline, an antagonist of cAMP-phosphodiesterase converting cAMP to AMP, enhanced the virusstimulating activity of DXMT as well as of prostaglandins. The enhancement of MuMTV production by adenylate cyclase agonists do not correlate absolutely with the estimates of intracellular cAMP levels, since the highest amounts of cAMP has been repeatedly observed in cells treated with PGE1 and norepinephrine. The results indicate that besides hormones, other hormonelike substances and cyclic nucleotides may be involved in the complex mechanism of hormone-regulated MuMTV genome expression.
Similar content being viewed by others
Abbreviations
- AMP:
-
adenosine 3′,5′-monophosphate
- cAMP:
-
adenosine 3′,5′-monophosphate, cyclic
- db-cAMP:
-
dibutyryl-adenosine 3′5′-monophosphate, cyclic
- DNA:
-
deoxyribonucleic acid
- DXMT:
-
dexamethasone
- ETYA:
-
eicosa-5,8, 11, 14-tetrayonic acid
- MEM:
-
minimum essential medium
- PGA:
-
prostaglandin A1
- PGB1 :
-
prostaglandin B1
- PGE1 :
-
prostaglandin E1
- PGF2α:
-
prostaglandin F2 alpha
- RNA:
-
ribonucleic acid
- TCA:
-
trichloroacetic acid
References
Ahren DG, Downing DT (1970) Inhibition of prostaglandin biosynthesis by eicosa-5,8, 11, 14-tetrayonic acid. Biochim Biphys Acta 210:456–461
Ariëns EJ, Simonis AM (1978) Receptors and receptor mechanism. In: Saxena RP, Forsyth RP (eds) Beta-adrenoceptor blocking agents North-Holland, Amsterdam, pp 3–27
Beavo JA, Bechtel PJ, Krebs EG (1974) Activation of protein kinase by physiological concentrations of cyclic AMP. Proc Natl Acad Sci USA 71:3580–3583
Bentvelzen P, Daams JH, Hageman P, Calafat J (1970) Genetic transmission of viruses that incite mammary tumors in mice. Proc Natl Acad Sci USA 67:377–384
Cheung WY (1967) Properties of cyclic 3′–5′ nucleotide phosphodiesterase from rat brain. Biochem 6:1079–1087
Cho-Chung YS (1980) Cyclic AMP and its receptor protein in tumor growth regulation in vitro. J Cyclic Nucleotide Res 6:163–177
Dickson C, Haslam S, Nandi S (1974) Conditions for optimal MMTV synthesis in vitro and the effect of steroid hormones on virus production. Virology 62:242–252
Feller N, Malachi T, Halbrecht I (1979) Prostaglandin E2 and cyclic AMP levels in human breast tumors. J Cancer Res Clin Oncol 93:275–280
Fine DL, Plowman JK, Kelley SP, Arthur LO, Hillman EA (1974) Enhanced production of mouse mammary tumor virus in dexamethasone-treated, 5-iododeoxyuridine-stimulated mammary tumor cell cultures. J Natl Cancer Inst 52:1881–1886
Flower RJ (1974) Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev 26:33–37
Foster SJ, Perkins JP (1977) Glucocorticoids increase the responsiveness of cells in culture to prostaglandin E1. Proc Natl Acad Sci USA 74:4816–4820
Fulton AM, Humes JL (1975) Prostaglandin synthesis inhibition. Effect on bone changes and sarcoma tumor induction in Balb/c mice. Int J Cancer 15:724–730
Fulton AM, Levy JG (1980) Inhibition of mouse tumor growth and prostaglandin synthesis by indomethacin. Int J Cancer 26:669–673
Higgins SJ, Gehring U (1978) Molecular mechanism of steroid hormone action. Adv Cancer Res 28:313–397
Hilgers J, Bentvelzen P (1977) Interactions between viral and genetic factors in murine mammary cancer. Adv Cancer Res 26:143–197
Jaffe BM (1974) Prostaglandins and cancer: An update. Prostaglandins 6:453–456
Jaffe BM, Santoro MG (1977) Prostaglandins and cancer. In: Ramwell PW (ed) The prostaglandins, vol III. Plenum Press, New York, pp 329–351
Karmali RA, Horrobin DF, Menezes J, Patel P (1979) The relationship between concentrations of prostaglandin A1, E1, E2, and F2 alpha, and rates of cell proliferation. Pharm Res Com 11:69–75
Kelly LA, Butcher RW (1974) The effect of epinephrine and PGE1 on cyclic adenosine 3′,5′-monophosphate levels in WI338 fibroblasts. J Biol Chem 249:3098–3104
Kibbey WE, Bronn DG, Minton JP (1979) Prostaglandin synthetase and prostaglandin E2 levels in human breast carcinoma. Prostagl Med 2:133–139
Kuehl FA, Egan RW (1980) Prostaglandins, arachidonic acid, and inflammation. Science 210:978–984
Lynch NR, Castes M, Astoin M, Salomon JC (1978) Mechanism of inhibition and portentiation of immunotherapy by indomethacin in mice. J Natl Cancer Inst 62:117–121
McGrath CM (1971) Replication of mammary tumor virus in tumor cell cultures: dependence on hormone-induced cellular organization. J Natl. Cancer Inst 47:455–467
McGrath CM, Martineau EJ, Voyles BA (1978) Changes in MuMTV DNA and RNA levels in Balb/c mammary epithelial cells during malignant transformation by exogenous MuMTV and hormones. Virology 87:339–353
McGrath CM, Jones RF (1978) Hormonal induction of mammary tumor viruses and its implications for carcinogenesis. Cancer Res 38:4112–4125
Michalides R, Schlom J (1975) Relationship in nucleic acid sequences between mouse mammary tumor virus variants. Proc Natl Acad Sci USA 72:4635–4639
Mühlbock O (1956) The hormonal genesis of mammary cancer. Adv Cancer Res 4:371–384
Nandi S (1978) Role of hormones in mammary neoplasia. Cancer Res 38:4046–4049
Nandi S, McGrath CM (1973) Mammary neoplasia in mice. Adv Cancer Res 17:353–414
Narayanan N, Wei JW, Sulakhe PV (1979) Differences in the cation sensitivity of adenylate cyclase from hearth and skeletal muscle: Modification by guanyl nucleotides ans isoproterenol. Arch Biochem Biophys 197:18–29
Owen K, Gomolka D, Droller MJ (1980) Production of prostaglandin E1 by tumor cells in vitro. Cancer Res 40:3167–3171
Owens RB, Hackett AJ (1972) Tissue culture studies of mouse mammary tumor cells and associated viruses. J Natl Cancer Inst 49:1321–1332
Parks WP, Scolnick EM, Kozikowski EH (1974) Dexamethasone stimulation of murine mammary tumor virus expression. A tissue culture source of virus. Science 184:158–160
Parks WP, Ranson JC, Young HA, Scolnick EM (1975) Mammary tumor virus induction by glucocorticoids. J Biol Chem 250:3330–3336
Pauley RJ, Medina D, Socher SH (1979) Hormonal regulation of murine mammary tumor virus RNA expression during mammary tumorigenesis in Balb/c mice. J Virol 32:557–566
Pentil J, Jard S, Benda P (1974) Probecid sensitive 3′,5′-cyclic AMP secretion by isoproterenol stimulated glial cells in culture. FEBS Lett 41:156–158
Perkins JP, Moore MM (1971) Adenylate cyclase of rat cerebral cortex. Activation by sodium fluoride and detergents. J Biol Chem 246:62–68
Powlers TJ, Clark SA, Easty DM, Easty GC (1973) The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcemia in rats with Walker tumor and its possible application to human breast cancer. Br J Cancer 28:316–321
Ringold CM, Cardiff RD, Varmus HE, Yamamoto KR (1977) Infection of cultured rat hepatoma cells by mouse mammary tumor virus. Cell 10:11–17
Ringold G, Lasfargues EY, Bishop HJ, Varmus HE (1975) Production of mouse mammary tumor virus by cultured cells in the absence and presence of hormones: assay by molecular hybridization. Virology 65:135–147
Robinson GA, Butcher RW, Sutherland EW (1971) Cyclic AMP and hormone action. In: Cyclic AMP. Academic Press, New York, pp 3–44
Rodbell M (1978) Cyclic nucleotides. In: Folco G, Paoletti R (eds) Molecular biology and pharmacology of cyclic nucleotides. Elsevier/North Holland Biomedical Press, pp 1–12
Rolland PH, Martin PM, Jacquemier J, Rolland AM, Toga M (1980) Prostaglandins in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J Natl Cancer Inst 64:1061–1070
Rolland PH, Martin PM, Rolland AM, Toga M (1979) Prostaglandins in breast cancer: Identification of a cytosolic prostaglandin-9-keto-reductase activity. Biomedicine 31:178–182
Samuelsson B, Goldyne M, Granstrom E, Hamberg M, Hammarstrom S, Malmstein C (1978) Prostaglandins and tromboxanes. Ann Rev Biochem 47:997–1029
Schlegel W, Kempner ES, Rodbell M (1979) Activation of adenylate cyclase in hepatic membranes involves interactions of the catalytic unit with multimeric complexes of regulatory proteins. J Biol Chem 254:5168–5176
Strausser HR, Humes JL (1975) Prostaglandin synthesis inhibition. Effect on bone changes and sarcoma tumor induction in Balb/c mice. Int J Cancer 15:724–730
Svec J, Links J (1977) Mouse mammary tumor virus production stimulated by hormones and polyamines in cells grown in semi-synthetic in vitro conditions. Int J Cancer 19:249–257
Svec J, Hlavayova E, Matoska J, Thurzo V (1979) Conditions for hormone-stimulated expression of endogenous C57BL strain-associated mammary tumor virus genome. Neoplasma 26:539–550
Tashjian AH (1978) Role of prostaglandins in the production of hypercalcemia by tumors. Cancer Res 38:4138–4141
Vaidya AB, Lasfargues EY, Heubel G, Lasfargues JC, Moore DH (1976) Murine mammary tumor virus. Characterization of infection of nonmurine cells. J Virol 18:911–917
Yang Y, Nandi S (1977) Cyclic AMP regulation of mammary tumor virus production. J Virol 21:815–819
Young HA, Scolnick EM, Parks WP (1975) Glucocorticoid-receptor interactions and induction of murine mammary tumor viruses. J Biol Chem 250:3337–3343
Yu JH, Wells H, Ryan WJ, Lloyd W (1976) Effects of prostaglandins and other drugs on the cyclic AMP content of cultured bone cells. Prostaglandins 12:501–511
Yu JH, Wells H, Moghadan B, Ryan WJ (1979) Cyclic AMP formation and release by cultured bone cells stimulated with prostaglandin E1. Prostaglandin 17:61–69
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Svec, J., Svec, P., Halcak, L. et al. Role of natural prostaglandins in the control of murine mammary tumor virus expression. J Cancer Res Clin Oncol 103, 55–67 (1982). https://doi.org/10.1007/BF00410306
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00410306